Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CSTL
CSTL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CSTL News
Castle Biosciences Grants Restricted Stock Units to Employees
15h ago
PRnewswire
Castle Biosciences Grants Restricted Stock Units to Employees
15h ago
Newsfilter
Castle Biosciences Surpasses 100,000 TissueCypher Test Orders
3d ago
PRnewswire
Castle Biosciences to Present at 2026 Jefferies Global Healthcare Conference
May 13 2026
PRnewswire
Castle Biosciences Wins Genomics Innovation Award for AdvanceAD-Tx Test
May 12 2026
PRnewswire
Castle Biosciences Reports Strong Q1 2026 Earnings with Raised Revenue Guidance
May 07 2026
seekingalpha
Castle Biosciences Unveils New Data on Melanoma Risk Assessment
Apr 21 2026
PRnewswire
Castle Biosciences to Release Q1 2026 Financial Results on May 6
Apr 15 2026
PRnewswire
Castle Biosciences Wins 2026 USA TODAY Top Workplaces Award for Fifth Year
Apr 10 2026
PRnewswire
Castle Biosciences Wins USA TODAY Top Workplaces Award for Fifth Year
Apr 10 2026
Newsfilter
Castle Biosciences Presents New Melanoma Survival Data at AAD 2026
Mar 27 2026
PRnewswire
Castle Biosciences Presents New Melanoma Survival Data at AAD 2026
Mar 27 2026
Newsfilter
Castle Biosciences Presents New Data on Sentinel Lymph Node Positivity Prediction
Mar 04 2026
Newsfilter
Castle Biosciences to Celebrate Grand Opening of New Headquarters
Mar 03 2026
Newsfilter
Castle Biosciences Reports Strong Q4 2025 Earnings with Revenue Growth
Feb 27 2026
seekingalpha
Castle Biosciences to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Show More News